Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Transplantation Proceedings

• Publication date

  1993-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8442093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease.

  1991cited by this paper
• Graft-versus-host disease.

  1991cited by this paper
• Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

  1990cited by this paper
• Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

  1990cited by this paper
• In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment

  1990cited by this paper
• Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor.

  1990cited by this paper
• Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.

  1990cited by this paper
• Quantitation of mRNA by the polymerase chain reaction.

  1989cited by this paper
• Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

  1988cited by this paper
• Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

  1987cited by this paper
• Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences

  1986cited by this paper
• Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

  1978cited by this paper
• The skin biopsy in the diagnosis of acute graft-versus-host disease in man.

  1977cited by this paper

• Host Responses to SARS-CoV-2 with an Emphasis on Cytokines

  2026cites this paper
• Cytokine storm in acute respiratory distress syndrome

  2026cites this paper
• Cytokine storm

  2026cites this paper
• Differential cytokine and chemokine signatures in bronchoalveolar lavage and plasma predict clinical outcomes of COVID-19 patients hospitalized in intensive care unit.

  2025cites this paper
• Analysis of the Innate Immune Response to Febrile UTI in Infants: Evidence of an Acute Cytokine Storm

  2025cites this paper
• The “cytokine storm” in infection and sepsis: win the battle but lose the war

  2025cites this paper
• Molecular dynamics simulation and docking studies reveals inhibition of NF-kB signaling as a promising therapeutic drug target for reduction in cytokines storms

  2025cites this paper
• Acute lung injury induced by recombinant SARS-CoV-2 spike protein subunit S1 in mice

  2025cites this paper
• The Concentration and Duration of Lipopolysaccharide Stimulation Produce Different Cytokine Responses in an Ex Vivo Whole Blood Model in Horses

  2025cites this paper
• The immunopathogenesis of a cytokine storm: The key mechanisms underlying severe COVID-19.

  2025cites this paper
• Hypoxia Exacerbates Inflammatory Signaling in Human Coronavirus OC43-Infected Lung Epithelial Cells

  2025cites this paper
• Deep insight into cytokine storm: from pathogenesis to treatment

  2025cites this paper
• Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease.

  2025cites this paper
• Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review.

  2024cites this paper
• IL-6 knockdown in a model of the human bone marrow, abrogates DNA damage induction in bystander cells post-chemotherapy induced cytokine release syndrome

  2024cites this paper
• Acute-phase proteins as indicators of disease severity and mortality in COVID-19 patients

  2024cites this paper
• Frontiers and hotspots evolution in cytokine storm: A bibliometric analysis from 2004 to 2022

  2024cites this paper
• The critical impacts of cytokine storms in respiratory disorders

  2024cites this paper
• Etoposide Therapy of Cytokine Storm Syndromes.

  2024cites this paper
• The COVID-19 Pandemic Heightens Interest in Cytokine Storm Disease and Advances in Machine Learning Diagnosis, Telemedicine, and Primordial Prevention of Rheumatic Diseases

  2024cites this paper
• Common for COVID-19 cytokine storm in patients with SARS-CoV-2 infection and CLL (chronic lymphocytic leukemia)

  2024cites this paper
• Interferon gene expression declines over time post-COVID infection and in long COVID patients

  2024cites this paper
• CAR T Cell Therapy in Hematology: Navigating Toxicities and Deciphering Patient Experiences Through Patient-Reported Outcomes

  2023cites this paper
• Monochasma savatieri Franch. protects against acute lung injury via α7nAChR - TLR4/NF-κB p65 signaling pathway based on integrated pharmacology analysis.

  2023cites this paper
• GENIPOSIDE IMPROVES CLP-INDUCED SEPSIS MODEL PROGNOSIS BY UPREGULATING PPARγ TO MODULATE MONOCYTE PHENOTYPE AND CYTOKINE NETWORK

  2023cites this paper
• The role of serum circulating microbial toxins in severity and cytokine storm of COVID positive patients

  2023cites this paper
• Impact of CytoSorb® on interleukin-6 in cardiac surgery

  2023cites this paper
• Acute Graft-versus-Host Disease: An Update on New Treatment Options

  2023cites this paper
• Hemodialysis: The Life Boat for AKI Patients in the COVID Cytokine Storm

  2023cites this paper
• Cytokine storm and translating IL-6 biology into effective treatments for COVID-19

  2023cites this paper
• Immunomodulating Phytochemicals: An Insight Into Their Potential Use in Cytokine Storm Situations

  2023cites this paper
• A brief overview of SARS-CoV-2 infection and its management strategies: a recent update

  2023cites this paper
• Emerging aspects of cytokine storm in COVID-19: the role of proinflammatory cytokines and therapeutic prospects

  2023cites this paper
• COVID-19 and hemophagocytic lymphohistiocytosis: A review of the intersection of viral infection and hyperinflammation

  2023cites this paper
• Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era

  2023cites this paper
• Is Nuclear Factor Erythroid 2-Related Factor 2 a Target for the Intervention of Cytokine Storms?

  2023cites this paper
• COVID19: uncovering interindividual variability for tailoring appropriate therapeutic interventions

  2022cites this paper
• Oral mucosal graft-versus-host disease and its possibility of antitumor effects

  2022cites this paper
• Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review)

  2022cites this paper
• Convergence of signalling pathways in innate immune responses and genetic formof Parkinson's disease.

  2022cites this paper
• An Overview of Systematic Reviews of the Role of Vitamin D on Inflammation in Patients with Diabetes and the Potentiality of Its Application on Diabetic Patients with COVID-19

  2022cites this paper
• Pathogenetic Mechanisms Of Dry Eye Syndrome In A Novel Coronavirus Infection Caused By SARS-CoV-2

  2022cites this paper
• Parkinsonism associated with viral infection.

  2022cites this paper
• Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?

  2022cites this paper
• The role of serum circulating microbial toxins in severity and cytokine storm of COVID positive patients

  2022cites this paper
• Lower level of IL‐28A as a predictive index of the artificial liver support system in effective treatment of patients with HBV‐ACLF

  2022cites this paper
• Cytokine Release Syndrome and Sepsis: Analogous Clinical Syndromes with Distinct Causes and Challenges in Management.

  2022cites this paper
• Exploring NFκB pathway as a potent strategy to mitigate COVID-19 severe morbidity and mortality

  2022cites this paper
• Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity

  2022cites this paper
• Challenging molecular dogmas in human sepsis using mathematical reasoning

  2022cites this paper
• The role of serum circulating microbial toxins in severity and cytokine storm of COVID positive patients

  2022cites this paper
• The role of serum circulating microbial toxins in severity and cytokine storm of COVID positive patients

  2022cites this paper
• The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19

  2022cites this paper
• Balanced cytokine upregulation by diluted ethanolic extract of Bryonia alba in Delta SARS-CoV-2 Spike protein RBD-induced pathogenesis in Gallus gallus embryo

  2022cites this paper
• The autonomic aspects of the post-COVID19 syndrome

  2022cites this paper
• An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection

  2022cites this paper
• Cytokine Storm—Definition, Causes, and Implications

  2022influential citation
• The Dual Role of Innate Immune Response in Acetaminophen-Induced Liver Injury

  2022cites this paper
• The novel biomarker, neopterin, can predict the severity of COVID-19.

  2022cites this paper
• Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19

  2022cites this paper
• Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence

  2022cites this paper
• Editorial: Two hits and four factors affecting the development of, or resistance to, transfusion-associated graft-versus-host disease.

  2022cites this paper
• COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy

  2022cites this paper
• Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review

  2022cites this paper
• Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza

  2022cites this paper
• Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome

  2022cites this paper
• Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis

  2022cites this paper
• High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs

  2022cites this paper
• SARS-CoV-2 and COVID-19: A Narrative Review

  2022cites this paper
• The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19

  2021cites this paper
• Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID‐19 and Multisystem Inflammatory Syndrome in Children

  2021cites this paper
• [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?]

  2021cites this paper
• The Roles of Neutrophils in Cytokine Storms

  2021influential citation
• Role of Mitochondria-Derived Danger Signals Released After Injury in Systemic Inflammation and Sepsis

  2021cites this paper
• Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: CON.

  2021cites this paper
• The effect of tocilizumab on severe COVID-19 infection: Review of current evidence.

  2021cites this paper
• [Management of cytokine release syndrome and macrophage activation syndrome following CAR-T cell therapy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

  2021cites this paper
• Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective

  2021cites this paper
• The cytokine storm and thyroid hormone changes in COVID-19

  2021cites this paper
• Neurological involvement in COVID-19

  2021cites this paper
• Association between cytokine levels, sepsis severity and clinical outcomes in sepsis: a quantitative systematic review protocol

  2021cites this paper
• Vitamin D and COVID-19: An Overview of Recent Evidence

  2021cites this paper
• имму-Critical appraisal of the “cytokine storm” concept in new coronavirus disease COVID-19. Review

  2021cites this paper
• Excitotoxicity (Immunoexcitotoxicity) as a Critical Component of the Cytokine Storm Reaction in Pulmonary Viral Infections, Including SARS-Cov-2

  2021cites this paper
• Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy

  2021cites this paper
• Capturing Cytokines with Advanced Materials: A Potential Strategy to Tackle COVID‐19 Cytokine Storm

  2021cites this paper
• Ischemic Stroke: An Underestimated Complication of COVID-19

  2021cites this paper
• Changes in the levels of some cytokines when using blood purification in COVID-19 patients

  2021cites this paper
• The 'cytokine storm': molecular mechanisms and therapeutic prospects.

  2021cites this paper
• COVID-19 Disease, Women’s Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay

  2021cites this paper
• Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective

  2021cites this paper
• Cardiovascular Burden of COVID-19 and the Post-Covid Era

  2021cites this paper
• RS-5645 attenuates inflammatory cytokine storm induced by SARS-CoV-2 spike protein and LPS by modulating pulmonary microbiota

  2021influential citation
• Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality

  2021cites this paper
• Managing the Cytokine Storm in COVID-19: Can Melatonin Play a Part?

  2021cites this paper
• Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases

  2021cites this paper
• Cytokine, cytokine storm and their role in fatalities of COVID-19

  2021cites this paper
• [The innate immune response to SARS-CoV-2].

  2021cites this paper
• Immunopathogenesis and treatment of cytokine storm in COVID-19

  2021cites this paper
• The interplay between the immune system and SARS-CoV-2 in COVID-19 patients

  2021cites this paper